tiprankstipranks
Trending News
More News >
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
US Market

Lexicon Pharmaceuticals (LXRX) Ratios

Compare
1,751 Followers

Lexicon Pharmaceuticals Ratios

LXRX's free cash flow for Q3 2025 was $1.00. For the 2025 fiscal year, LXRX's free cash flow was decreased by $ and operating cash flow was $-0.75. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.64 5.44 5.60 6.08 4.02
Quick Ratio
5.63 5.44 5.58 6.08 4.02
Cash Ratio
2.29 1.47 0.71 2.00 2.90
Solvency Ratio
-0.79 -1.31 -1.30 -1.33 -3.77
Operating Cash Flow Ratio
-2.22 -3.95 -5.13 -3.83 -3.93
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 36.76M$ 93.72M$ 40.23M$ 63.69M$ 65.61M
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.36 0.46 0.28 0.02
Debt-to-Equity Ratio
0.48 0.74 1.14 -0.03 >-0.01
Debt-to-Capital Ratio
0.33 0.43 0.53 -0.04 >-0.01
Long-Term Debt-to-Capital Ratio
0.32 0.41 0.52 -0.03 0.00
Financial Leverage Ratio
1.71 2.04 2.46 -0.12 -0.09
Debt Service Coverage Ratio
-4.75 -11.83 -12.48 -35.94 -108.70
Interest Coverage Ratio
-6.58 -12.65 -13.11 -36.24 -108.59
Debt to Market Cap
0.11 0.42 0.29 0.15 0.00
Interest Debt Per Share
0.19 0.39 0.54 0.35 0.02
Net Debt to EBITDA
-0.18 -0.23 -0.51 -0.09 0.71
Profitability Margins
Gross Profit Margin
63.05%98.02%92.94%-207.19%-18371.81%
EBIT Margin
-69.06%-594.65%-13622.76%-71341.01%-29179.87%
EBITDA Margin
-68.18%-592.93%-13576.74%-71033.81%-29081.88%
Operating Profit Margin
-94.36%-634.20%-14264.95%-72489.21%-29224.83%
Pretax Profit Margin
-96.77%-644.78%-14710.88%-73341.01%-29448.99%
Net Profit Margin
-96.77%-644.78%-14710.88%-74192.81%-29620.13%
Continuous Operations Profit Margin
-96.77%-644.78%-14710.88%-73341.01%-29448.99%
Net Income Per EBT
100.00%100.00%100.00%101.16%100.58%
EBT Per EBIT
102.56%101.67%103.13%101.18%100.77%
Return on Assets (ROA)
-33.30%-67.15%-77.20%-53.08%-64.47%
Return on Equity (ROE)
-52.90%-137.31%-190.23%6.49%5.93%
Return on Capital Employed (ROCE)
-36.30%-77.86%-86.79%-58.88%-75.87%
Return on Invested Capital (ROIC)
-35.98%-77.50%-86.23%-59.12%-75.60%
Return on Tangible Assets
-42.49%-78.94%-95.80%-68.86%-95.56%
Earnings Yield
-13.77%-84.79%-52.35%-32.58%-15.38%
Efficiency Ratios
Receivables Turnover
30.36 8.95 1.19 4.96 21.29
Payables Turnover
6.90 0.04 <0.01 0.04 6.01
Inventory Turnover
165.71 2.67 0.22 0.00 0.00
Fixed Asset Turnover
7.47 4.25 0.16 0.07 0.25
Asset Turnover
0.34 0.10 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
0.67 0.18 <0.01 <0.01 <0.01
Cash Conversion Cycle
-38.71 -8.59K -59.85K -8.81K -43.54
Days of Sales Outstanding
12.02 40.79 306.19 73.53 17.15
Days of Inventory Outstanding
2.20 136.88 1.64K 0.00 0.00
Days of Payables Outstanding
52.93 8.77K 61.79K 8.89K 60.69
Operating Cycle
14.22 177.66 1.94K 73.53 17.15
Cash Flow Ratios
Operating Cash Flow Per Share
-0.13 -0.56 -0.73 -0.54 -0.60
Free Cash Flow Per Share
-0.13 -0.56 -0.73 -0.54 -0.61
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.01 1.01 1.00 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
-101.85 -173.40 -344.46 -67.01 -71.27
Capital Expenditure Coverage Ratio
-101.85 -173.40 -344.46 -67.01 -71.27
Operating Cash Flow Coverage Ratio
-0.83 -1.65 -1.53 -1.61 -38.18
Operating Cash Flow to Sales Ratio
-0.68 -5.75 -134.47 -639.22 -292.00
Free Cash Flow Yield
-9.79%-76.08%-47.99%-28.49%-15.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.26 -1.18 -1.91 -3.07 -6.50
Price-to-Sales (P/S) Ratio
7.03 7.60 281.00 2.28K 1.93K
Price-to-Book (P/B) Ratio
4.14 1.62 3.63 -0.20 -0.39
Price-to-Free Cash Flow (P/FCF) Ratio
-10.21 -1.31 -2.08 -3.51 -6.50
Price-to-Operating Cash Flow Ratio
-10.31 -1.32 -2.09 -3.56 -6.59
Price-to-Earnings Growth (PEG) Ratio
-0.17 0.06 -0.07 -1.87 2.05
Price-to-Fair Value
4.14 1.62 3.63 -0.20 -0.39
Enterprise Value Multiple
-10.48 -1.51 -2.58 -3.30 -5.91
Enterprise Value
506.35M 278.08M 421.93M 325.50M 512.08M
EV to EBITDA
-10.48 -1.51 -2.58 -3.30 -5.91
EV to Sales
7.15 8.95 350.44 2.34K 1.72K
EV to Free Cash Flow
-10.39 -1.55 -2.60 -3.61 -5.80
EV to Operating Cash Flow
-10.49 -1.56 -2.61 -3.66 -5.88
Tangible Book Value Per Share
0.21 0.32 0.22 0.44 0.47
Shareholders’ Equity Per Share
0.33 0.46 0.42 -9.59 -10.21
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 -0.01 >-0.01
Revenue Per Share
0.20 0.10 <0.01 <0.01 <0.01
Net Income Per Share
-0.19 -0.63 -0.80 -0.62 -0.61
Tax Burden
1.00 1.00 1.00 1.01 1.01
Interest Burden
1.40 1.08 1.08 1.03 1.01
Research & Development to Revenue
1.08 2.72 48.91 379.97 184.72
SG&A to Revenue
0.00 0.00 0.00 345.92 0.00
Stock-Based Compensation to Revenue
0.11 0.43 11.91 82.88 35.49
Income Quality
0.70 0.89 0.91 0.87 0.99
Currency in USD